BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 41 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -54.7% | 59,499 | -23.0% | 0.00% | – |
| Q2 2023 | $53 | -96.0% | 77,299 | -54.5% | 0.00% | -100.0% |
| Q1 2023 | $1,341 | +765.2% | 169,899 | -1.1% | 0.00% | – |
| Q4 2022 | $155 | -99.9% | 171,799 | -12.4% | 0.00% | – |
| Q3 2022 | $214,000 | -17.1% | 196,191 | -6.3% | 0.00% | – |
| Q2 2022 | $258,000 | -41.0% | 209,399 | +13.0% | 0.00% | -100.0% |
| Q1 2022 | $437,000 | -21.3% | 185,299 | +3.6% | 0.00% | 0.0% |
| Q4 2021 | $555,000 | -32.2% | 178,899 | -11.3% | 0.00% | 0.0% |
| Q3 2021 | $819,000 | -34.2% | 201,706 | -21.5% | 0.00% | -50.0% |
| Q2 2021 | $1,244,000 | +2.6% | 257,072 | +10.0% | 0.00% | 0.0% |
| Q1 2021 | $1,213,000 | -15.1% | 233,799 | +9.1% | 0.00% | 0.0% |
| Q4 2020 | $1,429,000 | -43.5% | 214,299 | -13.7% | 0.00% | -33.3% |
| Q3 2020 | $2,528,000 | -32.4% | 248,311 | -16.7% | 0.00% | 0.0% |
| Q2 2020 | $3,741,000 | +128.8% | 298,111 | +99.8% | 0.00% | +50.0% |
| Q1 2020 | $1,635,000 | – | 149,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFS Partners, LLC | 6,000 | $2,386 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 383,178 | $152 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 113,911 | $45,291 | 0.00% |
| OSAIC HOLDINGS, INC. | 557 | $221 | 0.00% |
| US BANCORP \DE\ | 1,221 | $485 | 0.00% |
| WELLS FARGO & COMPANY/MN | 180,066 | $71,594 | 0.00% |
| NORTHERN TRUST CORP | 30,251 | $12,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,656 | $38,262 | 0.00% |